Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.

Zhao Y, Alakhova DY, Kim JO, Bronich TK, Kabanov AV.

J Control Release. 2013 May 28;168(1):61-9. doi: 10.1016/j.jconrel.2013.02.026. Epub 2013 Mar 6.

PMID:
23474033
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers.

Hong W, Chen D, Zhang X, Zeng J, Hu H, Zhao X, Qiao M.

Biomaterials. 2013 Dec;34(37):9602-14. doi: 10.1016/j.biomaterials.2013.08.032. Epub 2013 Sep 7.

PMID:
24021757
[PubMed - indexed for MEDLINE]
3.

Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models.

Gabizon A, Tzemach D, Mak L, Bronstein M, Horowitz AT.

J Drug Target. 2002 Nov;10(7):539-48.

PMID:
12683721
[PubMed - indexed for MEDLINE]
4.

Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.

Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.

Cancer Chemother Pharmacol. 2010 May;66(1):43-52. doi: 10.1007/s00280-009-1132-4. Epub 2009 Sep 25.

PMID:
19779718
[PubMed - indexed for MEDLINE]
5.

A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.

Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.

Curr Cancer Drug Targets. 2010 May;10(3):343-53.

PMID:
20370682
[PubMed - indexed for MEDLINE]
6.

A novel two-step mild hyperthermia for advanced liposomal chemotherapy.

Li L, ten Hagen TL, Haeri A, Soullié T, Scholten C, Seynhaeve AL, Eggermont AM, Koning GA.

J Control Release. 2014 Jan 28;174:202-8. doi: 10.1016/j.jconrel.2013.11.012. Epub 2013 Nov 22.

PMID:
24269966
[PubMed - indexed for MEDLINE]
7.

Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin.

Zhao C, Feng Q, Dou Z, Yuan W, Sui C, Zhang X, Xia G, Sun H, Ma J.

PLoS One. 2013 Sep 11;8(9):e73860. doi: 10.1371/journal.pone.0073860. eCollection 2013.

PMID:
24040096
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.

Jung SH, Jung SH, Seong H, Cho SH, Jeong KS, Shin BC.

Int J Pharm. 2009 Dec 1;382(1-2):254-61. doi: 10.1016/j.ijpharm.2009.08.002. Epub 2009 Aug 8.

PMID:
19666094
[PubMed - indexed for MEDLINE]
9.

Doxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer models.

Apte A, Koren E, Koshkaryev A, Torchilin VP.

Cancer Biol Ther. 2014 Jan;15(1):69-80. doi: 10.4161/cbt.26609. Epub 2013 Oct 21.

PMID:
24145298
[PubMed - indexed for MEDLINE]
10.

Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.

Arima H, Hagiwara Y, Hirayama F, Uekama K.

J Drug Target. 2006 May;14(4):225-32.

PMID:
16777681
[PubMed - indexed for MEDLINE]
11.

Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.

Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y.

Cancer Res. 1994 Feb 15;54(4):987-92.

PMID:
8313389
[PubMed - indexed for MEDLINE]
12.

Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery.

Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kim K, Kwon IC, Kim DD.

J Control Release. 2014 Jan 28;174:98-108. doi: 10.1016/j.jconrel.2013.11.016. Epub 2013 Nov 23.

PMID:
24280260
[PubMed - indexed for MEDLINE]
13.

Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.

Li L, ten Hagen TL, Hossann M, Süss R, van Rhoon GC, Eggermont AM, Haemmerich D, Koning GA.

J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21.

PMID:
23524188
[PubMed - indexed for MEDLINE]
14.

Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C.

J Control Release. 2012 Mar 10;158(2):319-28. doi: 10.1016/j.jconrel.2011.10.028. Epub 2011 Oct 28.

PMID:
22063003
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
[PubMed - indexed for MEDLINE]
16.

A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas.

Lee CC, Gillies ER, Fox ME, Guillaudeu SJ, Fréchet JM, Dy EE, Szoka FC.

Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16649-54. Epub 2006 Oct 30.

PMID:
17075050
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).

Park SM, Kim MS, Park SJ, Park ES, Choi KS, Kim YS, Kim HR.

J Control Release. 2013 Sep 28;170(3):373-9. doi: 10.1016/j.jconrel.2013.06.003. Epub 2013 Jun 13.

PMID:
23770213
[PubMed - indexed for MEDLINE]
18.

Ultrasound improves the uptake and distribution of liposomal Doxorubicin in prostate cancer xenografts.

Eggen S, Afadzi M, Nilssen EA, Haugstad SB, Angelsen B, Davies Cde L.

Ultrasound Med Biol. 2013 Jul;39(7):1255-66. doi: 10.1016/j.ultrasmedbio.2013.02.010. Epub 2013 Apr 30.

PMID:
23643054
[PubMed - indexed for MEDLINE]
19.

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells.

Ogawara K, Un K, Tanaka K, Higaki K, Kimura T.

J Control Release. 2009 Jan 5;133(1):4-10. doi: 10.1016/j.jconrel.2008.09.008. Epub 2008 Sep 20.

PMID:
18840484
[PubMed - indexed for MEDLINE]
20.

In vitro and in vivo characterizations of PEGylated liposomal doxorubicin.

Jiang W, Lionberger R, Yu LX.

Bioanalysis. 2011 Feb;3(3):333-44. doi: 10.4155/bio.10.204. Review.

PMID:
21320053
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk